1
|
Asgedom YS, Kebede TM, Seifu BL, Mare KU, Asmare ZA, Asebe HA, Kase BF, Shibeshi AH, Tebeje TM, Sabo KG, Fente BM, Lombebo AA, Koyira MM, Kassie GA. Human papillomavirus vaccination uptake and determinant factors among adolescent schoolgirls in sub-Saharan Africa: A systematic review and meta-analysis. Hum Vaccin Immunother 2024; 20:2326295. [PMID: 38505959 PMCID: PMC10956624 DOI: 10.1080/21645515.2024.2326295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2023] [Accepted: 02/29/2024] [Indexed: 03/21/2024] Open
Abstract
Despite the ongoing global vaccination campaign aimed at preventing human papillomavirus (HPV) related health issues, the uptake of the HPV vaccine remains unacceptably low in developing regions, particularly in sub-Saharan Africa (SSA). Therefore, this systematic review and meta-analysis aimed at determining the pooled prevalence and associated factors of HPV vaccine uptake among adolescent school girls in SSA. Electronic bio-medical databases were explored. Pooled prevalence, publication bias, meta-regression, sub-group, and sensitivity analysis were performed. The estimated pooled prevalence of HPV vaccine uptake was 28.53% [95% CI: (5.25, 51.81)]. Having good knowledge and a positive attitude was significantly associated with HPV vaccine uptake in SSA. Subgroup analysis revealed the highest uptake was 62.52% from Kenya and the lowest was 3.77% in Nigeria. The HPV vaccine uptake is low. It underscores the need for community education, school-based immunization, and education programs that promote the uptake of the vaccine to increase coverage.
Collapse
Affiliation(s)
| | | | - Beminate Lemma Seifu
- Department of Public Health, College of Medicine and Health Science, Samara University, Afar, Ethiopia
| | - Kusse Urmale Mare
- Department of Nursing, College of Medicine and Health Sciences, Samara University, Afar, Ethiopia
| | - Zufan Alamrie Asmare
- Department of Ophthalmology, School of Medicine and Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia
| | - Hiwot Altaye Asebe
- Department of Public Health, College of Medicine and Health Science, Samara University, Afar, Ethiopia
| | - Bizunesh Fantahun Kase
- Department of Public Health, College of Medicine and Health Science, Samara University, Afar, Ethiopia
| | - Abdu Hailu Shibeshi
- Department of Statistics, College of Natural and Computational Science, Samara University, Afar, Ethiopia
| | - Tsion Mulat Tebeje
- School of Public Health, College of Health Science and Medicine, Dilla University, Dilla, Ethiopia
| | - Kebede Gemeda Sabo
- Department of Nursing, College of Medicine and Health Sciences, Samara University, Afar, Ethiopia
| | - Bezawit Melak Fente
- Department of General Midwifery, School of Midwifery, University of Gondar, Gondar, Ethiopia
| | - Afework Alemu Lombebo
- School of Medicine, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia
| | - Mengistu Meskele Koyira
- School of Public Health, College of Health Sciences and Medicine, Wolaita Sodo University, Wolaita Sodo, Ethiopia
| | | |
Collapse
|
2
|
Ogbolu MO, Eniade OD, Majiya H, Kozlovszky M. Factors Associated with HPV Genital Warts: A Self-Reported Cross-Sectional Study among Students and Staff of a Northern University in Nigeria. Viruses 2024; 16:902. [PMID: 38932194 PMCID: PMC11209233 DOI: 10.3390/v16060902] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 05/30/2024] [Accepted: 05/31/2024] [Indexed: 06/28/2024] Open
Abstract
The menace of human papillomavirus (HPV) infections among low- and middle-income countries with no access to a free HPV vaccine is a public health concern. HPV is one of the most common sexually transmitted infections (STIs) in Nigeria, while the most known types of HPV genotypes being transmitted are the high-risk HPV-16 and 18 genotypes. In this study, we explored the predictors of self-reported HPV infections and HPV genital warts infection among a population of students, non-academic staff, and academic staff of Ibrahim Badamasi Babangida (IBB) University located in Lapai, Nigeria. We also assessed their knowledge about HPV infections and genotypes, and sexual behaviors. An online cross-sectional study was conducted by setting up a structured questionnaire on Google Forms and it was distributed to the university community via Facebook and other social media platforms of the university. The form captured questions on HPV infection, and knowledge about HPV infection and genotypes, as well as the sexual health of the participants. All variables were described using frequencies and percentage distribution; chi-squared test statistics were used to explore the association between HPV infection (medical records of HPV infection) and the participants' profile, and a logistic regression analysis was performed to examine the factors associated with HPV genital warts infection among the population. This study reveals those participants between the ages of 26-40 years (81.3%) and those currently not in a sexually active relationship-single/divorced (26.4%)-who have self-reported having the HPV-16 and -18 genotypes. Moreover, participants between 26-40 years of age (OR: 0.45, 95%CI: 0.22-0.89) reported themselves to be carriers of HPV genital warts. Therefore, this study reveals the factors associated with HPV infection and genital warts peculiar to IBB university students and staff. Hence, we suggest the need for HPV awareness programs and free HPV vaccine availability at IBB university.
Collapse
Affiliation(s)
- Melvin Omone Ogbolu
- BioTech Research Center, University Research and Innovation Center, Óbuda University, Bécsi Street 96/B, 1034 Budapest, Hungary
| | - Olanrewaju D. Eniade
- Department of Epidemiology and Medical Statistics, College of Medicine, University of Ibadan, CW22+H4W, Queen Elizabeth II Road, Agodi, Ibadan 200285, Nigeria;
- International Foundation against Infectious Disease in Nigeria (IFAIN), 6A, Dutse Street, War College Estate, Gwarimpa, Abuja 900108, Nigeria
| | - Hussaini Majiya
- Department of Microbiology, Ibrahim Badamasi Babangida University, 3H89+XW3, Minna Road, Lapai 911101, Nigeria;
| | - Miklós Kozlovszky
- John von Neumann Faculty of Informatics, Óbuda University, Bécsi Street 96/B, 1034 Budapest, Hungary;
- Medical Device Research Group, LPDS, Institute for Computer Science and Control (SZTAKI), Hungarian Research Network (HUN-REN), 1111 Budapest, Hungary
| |
Collapse
|
3
|
Akinsolu FT, Abodunrin O, Adewole IE, Olagunju M, Gambari AO, Raji DO, Idigbe IE, Njuguna DW, Salako A, Ezechi OC. Willingness to Pay for HPV Vaccine among Women Living with HIV in Nigeria. Vaccines (Basel) 2023; 11:vaccines11050928. [PMID: 37243032 DOI: 10.3390/vaccines11050928] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/21/2023] [Revised: 04/10/2023] [Accepted: 04/19/2023] [Indexed: 05/28/2023] Open
Abstract
BACKGROUND Human papillomavirus (HPV) is responsible for most cervical cancer cases globally, with women living with HIV having a higher risk of persistent HPV infection and HPV-associated disease. The HPV vaccine is a promising tool to reduce cervical cancer rates, but its uptake among women living with HIV in Nigeria is unknown. METHODS A facility-based, cross-sectional survey was conducted with 1371 women living with HIV to assess their knowledge of HPV, cervical cancer, and the HPV vaccine as well as their willingness to pay for the vaccine at the HIV treatment clinic at the Nigerian Institute of Medical Research, Lagos. To identify factors associated with the willingness to pay for the HPV vaccine, multivariable logistic regression models were developed. RESULTS This study found that 79.1% of participants had not heard of the vaccine, and only 29.0% knew its efficacy in preventing cervical cancer. In addition, 68.3% of participants were unwilling to pay for the vaccine, and the average amount they were willing to pay was low. Knowledge of HPV, the HPV vaccine, and cervical cancer and income were factors associated with the willingness to pay for the vaccine. Health workers were the primary source of information. CONCLUSIONS This study highlights the lack of knowledge and low willingness to pay for the HPV vaccine among women living with HIV in Nigeria and emphasizes the importance of improving education and awareness. Factors associated with the willingness to pay, such as income and knowledge, were identified. Practical strategies, such as community outreach and school-based education programs, could be developed to increase vaccine uptake. Further research is needed to explore additional factors influencing the willingness to pay.
Collapse
Affiliation(s)
- Folahanmi T Akinsolu
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
- Nigerian Institute of Medical Research, Lagos 100001, Nigeria
| | - Olunike Abodunrin
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
- Lagos State Health Management Agency, Lagos 100001, Nigeria
| | - Ifeoluwa E Adewole
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
| | - Mobolaji Olagunju
- Department of Epidemiology and Biostatistics, School of Public Health, Nanjing Medical University, Nanjing 210008, China
| | - Aisha O Gambari
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
- Nigerian Institute of Medical Research, Lagos 100001, Nigeria
| | - Dolapo O Raji
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
| | - Ifeoma E Idigbe
- Nigerian Institute of Medical Research, Lagos 100001, Nigeria
| | - Diana W Njuguna
- School of Nursing, Dedan Kimathi University of Technology, Nyeri 10100, Kenya
| | - Abideen Salako
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
- Nigerian Institute of Medical Research, Lagos 100001, Nigeria
| | - Oliver C Ezechi
- Department of Public Health, Faculty of Basic Medical and Health Sciences, Lead City University, Ibadan 212102, Nigeria
- Nigerian Institute of Medical Research, Lagos 100001, Nigeria
| |
Collapse
|
4
|
Gautier S, Luyt D, Davido B, Herr M, Cardot T, Rousseau A, Annane D, Delarocque-Astagneau E, Josseran L. Cross-sectional study on COVID-19 vaccine hesitancy and determinants in healthcare students: interdisciplinary trainings on vaccination are needed. BMC MEDICAL EDUCATION 2022; 22:299. [PMID: 35443661 PMCID: PMC9020813 DOI: 10.1186/s12909-022-03343-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/23/2021] [Accepted: 03/29/2022] [Indexed: 06/04/2023]
Abstract
BACKGROUND To ensure the success of COVID-19 vaccination, public authorities need to have the support of the entire population and build vaccine confidence. Identifying and understanding the determinants of vaccine acceptance is essential for conducting vaccine strategy. The aim was to estimate vaccine hesitancy among healthcare students in France and to investigate the associated factors. METHODS A web-based cross-sectional study was conducted in a large French University in greater Paris area, among 4927 healthcare students from the different training courses such as medicine studies, midwifery studies, physiotherapy studies, nurse studies and others health studies. The study was conducted between January 21 and February 8, 2021 based on a questionnaire including 25 single or multiple-choice questions, made using the free software Limesurvey. The link of the questionnaire was distributed to the students by the teachers and the student associations. The SAGE group definition of vaccine hesitancy was used. All estimates were weighted using the gender and training courses category of all healthcare students registered for the 2020-2021 year. Crude and adjusted weighted odds ratio (wOR) and 95% confidence interval (95%CI) were estimated using logistic regression. RESULTS A total of 1465 healthcare students answered. A proportion of 44.5% (95%CI = [41.7-47.3]) of them were considered as hesitant. Women were more hesitant (50.9, 95%CI = [48.0-53.9]) than men (21.6, 95%CI = [15.2-28.0]). Vaccine hesitancy was significantly associated with gender (wOR = 0.27, 95%CI = [0.18-0.39]) and training courses: medical students were less likely to be hesitant than students in the common and first year of several health studies (wOR = 0.48, 95%CI = [0.33-0.70]) while nursing students were more than 5 times more likely to be hesitant (wOR = 5.20, 95%CI = [3.71-7.28]). Students who did an internship during the epidemic (wOR = 0.53, 95%CI = [0.41-0.69]) and who downloaded the mobile contact-tracing mobile app "TousAntiCovid" (wOR = 0.34, 95%CI = [0.26-0.44]) were significantly less likely to be hesitant. CONCLUSIONS Overall vaccine hesitancy among healthcare students was high, substantial differences were found between training courses. To reduce these disparities, interdisciplinary lectures on vaccines for all healthcare students may be implemented and evaluated.
Collapse
Affiliation(s)
- Sylvain Gautier
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France.
- Inserm U1018, CESP, Primary Care and Prevention team, University of Paris Saclay, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.
| | - Domitille Luyt
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
| | - Benjamin Davido
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Infectious diseases Department, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
| | - Marie Herr
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
- Inserm U1018, CESP, Anti-Infective Evasion and Pharmacoepidemiology team, University of Paris Saclay, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| | - Thomas Cardot
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
| | - Anne Rousseau
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Midwifery Department, Versailles Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux, France
- Department of Obstetrics and Gynecology, Poissy-Saint-Germain en Laye Hospital, Poissy, France
- Inserm U1018, CESP, Clinical Epidemiology team, University of Paris Saclay, Université of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| | - Djillali Annane
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- FHU SEPSIS (Saclay and Paris Seine Nord Endeavour to PerSonalize Interventions for Sepsis), RHU RECORDS (Rapid rEcognition of CORticosteroiD resistant or sensitive Sepsis), Department of Intensive Care, Hôpital Raymond Poincaré (AP-HP), Laboratory of Infection & Inflammation - U1173, University Versailles Saint Quentin - University Paris Saclay, INSERM, 92380, Garches, France
| | - Elisabeth Delarocque-Astagneau
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
- Inserm U1018, CESP, Anti-Infective Evasion and Pharmacoepidemiology team, University of Paris Saclay, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| | - Loïc Josseran
- Faculty of Health Sciences Simone Veil, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
- Hospital Department of Epidemiology and Public Health, Raymond Poincaré Hospital, GHU University of Paris Saclay, Assistance Publique - Hôpitaux de Paris, Garches, France
- Inserm U1018, CESP, Primary Care and Prevention team, University of Paris Saclay, University of Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| |
Collapse
|